LAS INFECCIONES DE TRANSMISIÓN SEXUAL. - Euskadi.net

172. Mullen P D, Ramirez G, Strouse D, Hedges
L V, Sogolow E. Meta-analysis of the effects
of behavioral HIV prevention interventions
on the sexual risk behavior of
sexually experienced adolescents in controlled
studies in the United States. J Acq
Immun Defic Syndr 2002; 30(Supplement
1): S94-S105.
173. Munoz N, Bosch FX. The causal link between
HPV and cervical cancer and its implications
for the prevention of cervical
cancer, Bull Pan-American Health Org
1996; 30:362-77.
174. Munoz N. Human papillomavirus and
cancer: the epidemiological evidence, J
Clin Virology 2000; 19(1-2):1-5.
175. Musicco M, Lazzarin A, Nicolosi A, Gasparini
M, Costigliola P, Arici C, Saracco .Antiretroviral
treatment of men infected with
human immunodeficiency virus type 1
reduces the incidence of heterosexual
transmission. Italian Study Group on HIV
Heterosexual Transmission. Arch Intern
Med 1994 Sep 12; 154(17):1971-6.
176. Myer L, Morroni C, Mathews C, Tholandi
M. Structural and community-level interventions
for increasing condom use to
prevent HIV and other sexually transmitted
infections. (Protocol for a Cochrane
Review). In: The Cochrane Library, Issue
2, 2003.
177. Nelson H, Saha S, HelfandM. Screening
for Chlamydial Infection. Systematic
Evidence Review. N. 3. 2001. En:
http://www.ncbi.nlm.nih.gov/books/bv.
fcgirid=hstat3.chapter.938. Acceso el
8/8/2005.
178. Nelson H; Glass N; Huffman L, Villemyer
K, Hamilton A, Frame P, Berg AO. Screening
for Syphilis: Brief Update for the U.S.
Preventive Services Task Force. 2004. Acceso
el 8/8/2005 en: http://www.
ahrq.gov/clinic/3rduspstf/syphilis/syphilup.pdf.
179. Nelson HD, Helfand M. Screening for chlamydial
infection. Am J Prev Med 2001
Apr; 20(3 Suppl): 95-107.
180. Neumann M S, Johnson W D, Semaan S,
Flores S A, Peersman G, Hedges L V, Sogolow
E. Review and meta-analysis of
HIV prevention intervention research for
heterosexual adult populations in the
United States. J Acq Immun Defic Syndr
2002; 30(Supplement 1): S106-S117.
181. Niccolai LM, Rowhani-Rahbar A, Jenkins
H, Green S, Dunne DW. Condom effectiveness
for prevention of Chlamydia trachomatis
infection Sexually Transmitted
Infections 2005; 81:323-325.
182. Nieminen P, Vuorma S, Viikki M, Hakama
M, Anttila A. Comparison of HPV test versus
conventional and automation-assisted
Pap screening as potential screening
tools for preventing cervical cancer.
BJOG 2004 Aug; 111(8):842-8.
183. NIH. National Institute of Allergy and Infectious
Diseases. Workshop summary: Scientific
evidence on condom effectiveness for
sexually transmitted disease prevention.
National Institutes of Health, 2001.
184. Niruthisard S, Roddy RE, Chutivongse
S.Use of nonoxynol-9 and reduction in
rate of gonococcal and chlamydial cervical
infections. Lancet 1992 Jun 6; 339
(8806):1371-5.
185. O’Brien TR, Busch MP, Donegan E, Ward
JW, Wong L, Samson SM, Perkins HA, Altman
R, Stoneburner RL, Holmberg SD.
Heterosexual transmission of human immunodeficiency
virus type 1 from transfusion
recipients to their sex partners. J
Acquir Immune Defic Syndr 1994 Jul; 7
(7):705-10.
186. Oxman A D, Scott E A, Sellors J W, Clarke
J H, Millson M E, Rasooly I, Frank J W, Naus
M, Goldblatt E. Partner notification for
sexually transmitted diseases: an overview
of the evidence. Can J Pub Health
1994; 85(Supplement 1):S41-S47.
168